CINECA IRIS Institutional Research Information System

TURCHETTI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.287
AS - Asia 1.354
EU - Europa 1.110
SA - Sud America 207
AF - Africa 127
Continente sconosciuto - Info sul continente non disponibili 72
OC - Oceania 2
Totale 5.159
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.216
SG - Singapore 442
CN - Cina 298
IT - Italia 285
SE - Svezia 187
HK - Hong Kong 182
BR - Brasile 176
DE - Germania 151
VN - Vietnam 148
GB - Regno Unito 103
IN - India 85
FR - Francia 76
FI - Finlandia 68
BG - Bulgaria 54
CI - Costa d'Avorio 52
CA - Canada 47
JP - Giappone 43
NL - Olanda 38
TR - Turchia 37
AT - Austria 29
RU - Federazione Russa 25
SN - Senegal 23
ID - Indonesia 21
BD - Bangladesh 17
NG - Nigeria 17
PL - Polonia 16
UA - Ucraina 16
KR - Corea 15
ZA - Sudafrica 15
ES - Italia 13
AR - Argentina 11
PK - Pakistan 10
IQ - Iraq 9
MX - Messico 9
PT - Portogallo 8
SA - Arabia Saudita 8
AZ - Azerbaigian 7
BE - Belgio 6
CH - Svizzera 6
CZ - Repubblica Ceca 6
MA - Marocco 5
TT - Trinidad e Tobago 5
VE - Venezuela 5
CL - Cile 4
CR - Costa Rica 4
EC - Ecuador 4
EG - Egitto 4
IR - Iran 4
LT - Lituania 4
LV - Lettonia 4
PH - Filippine 4
DZ - Algeria 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
MY - Malesia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
CO - Colombia 2
GE - Georgia 2
HR - Croazia 2
IL - Israele 2
PA - Panama 2
PE - Perù 2
RO - Romania 2
RS - Serbia 2
TN - Tunisia 2
UZ - Uzbekistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
IE - Irlanda 1
JM - Giamaica 1
MD - Moldavia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
PS - Palestinian Territory 1
PY - Paraguay 1
SI - Slovenia 1
SR - Suriname 1
SV - El Salvador 1
UY - Uruguay 1
Totale 5.089
Salva come PNG Salva come JPEG
Città #
Ashburn 310
Singapore 255
Dallas 237
Hong Kong 180
San Jose 175
Santa Clara 144
Chandler 125
Ann Arbor 82
Shanghai 75
Munich 64
Fairfield 59
Beijing 55
New York 55
Serra 55
Ho Chi Minh City 54
Sofia 54
Los Angeles 53
Abidjan 52
Florence 43
London 41
Boardman 39
Houston 39
Turku 36
Tokyo 34
Hanoi 33
Princeton 30
Wilmington 30
Seattle 29
Pisa 27
Woodbridge 27
Vienna 26
Council Bluffs 25
Lauterbourg 24
Dakar 23
Frankfurt am Main 23
Lawrence 23
Helsinki 22
Milan 21
Bremen 19
Hyderabad 18
Medford 18
Buffalo 17
Hefei 17
Lagos 17
Istanbul 16
Lancaster 16
Redwood City 15
Rome 15
Warsaw 14
Düsseldorf 13
Izmir 13
Ottawa 13
Redondo Beach 13
Seoul 13
São Paulo 13
Jacksonville 12
Cambridge 11
Fuzhou 11
Jakarta 11
Ogden 11
Atlanta 10
Chennai 10
Johannesburg 10
Kent 10
Phoenix 10
Montreal 9
Rio de Janeiro 9
San Diego 9
Belo Horizonte 8
Haiphong 8
Washington 8
Baku 7
Chicago 7
Dearborn 7
Mumbai 7
Nanjing 7
Orem 7
Amsterdam 6
Brussels 6
Livorno 6
Madrid 6
Manchester 6
Marseille 6
Naples 6
San Francisco 6
Toronto 6
Bengaluru 5
Columbus 5
Curitiba 5
Denver 5
Des Moines 5
Duncan 5
Goiânia 5
Hải Dương 5
Poplar 5
Portsmouth 5
Stockholm 5
Torres Vedras 5
Vancouver 5
Bari 4
Totale 3.261
Salva come PNG Salva come JPEG
Nome #
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis 266
Diagnosis and referral of rheumatoid arthritis by primary care physician: results of a pilot study on the city of Pisa, Italy 191
Minimally invasive distal pancreatectomy: a case-matched cost-analysis between robot-assisted surgery and direct manual laparoscopy 185
Direct health care costs among patients with rheumatoid arthritis before and after the initiation of treatment with JAKi in Tuscany: The LEONARDO study 182
Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy 176
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet’s syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial 172
A case-matched cost-analysis of robot-assisted versus open pancreatoduodenectomy: Can the higher costs of advanced technology be offset by clinical advantages? 164
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 163
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases 163
Robot-assisted pancreatoduodenectomy with the da Vinci Xi: can the costs of advanced technology be offset by clinical advantages? A case-matched cost analysis versus open approach 154
TABLET TOSCANA to Develop Innovative Organizational Models for Tele-Rehabilitation in Subjects with Congenital and Acquired Developmental Disabilities: A Wait-List Control Group Trial Protocol 146
Duration of response after DEB-TACE compared to lipiodol-TACE in HCC-naïve patients: a propensity score matching analysis 144
RESEZIONI PANCREATICHE NEGLI ANZIANI: NE VALE LA PENA?. 142
Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact 137
Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy 136
FIVE-YEAR EXPERIENCE OF ROBOTIC VS LAPAROSCOPIC RECTAL CANCER SURGERY IN A SINGLE CENTER: SURGICAL PARAMETERS AND COSTS ASSESSING ROBOTIC LEARNING CURVE 135
Utilization patterns and healthcare accesses of JAKi used in rheumatoid arthritis patients in Tuscany: The LEONARDO study 134
Structured cost analysis of robotic TME resection for rectal cancer: a comparison between the da Vinci Si and Xi in a single surgeon’s experience 129
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy 129
THE ECONOMIC IMPACT OF THE INTRODUCTION OF INFLIXIMAB-BIOSIMILAR: AN EMPIRICAL ANALYSIS USING THE TUSCANY HEALTHCARE ADMINISTRATIVE DATABASES 129
Evaluation of drug-utilization and healthcare facilities use in patients with ulcerative colitis and treated with biologic therapy using data of an Italian healthcare administrative database: Results from michelangelo study 128
How Italy Tweeted about COVID-19: Detecting Reactions to the Pandemic from Social Media 125
Sleep quality mediates the effect of chronotype on resilience in the time of COVID-19 123
RESEZIONI PANCREATICHE IN PAZIENTI OVER 70 122
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy 121
Changes in the consumption in fruits and vegetables among university students during master courses: an analysis of data collected from cashier transaction 121
COST-OPPORTUNITY OF PANCREATIC RESECTIONS IN ELDERLY 120
Robot-assisted rehabilitation for children with neurological disabilities: Results of the Italian consensus conference CICERONE 116
A Model-Based Analysis on Direct Costs of Adverse Drug Events and Related Cost-Savings Achievable by their Prevention in Tuscany, Italy 113
null 108
The Economic Impact of Post-Traumatic Stress Disorder Among Patients with Systemic Autoimmune Diseases During the COVID-19 Pandemic 106
Switching from infliximab-originator to infliximab-biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy 101
null 99
Cost-Effectiveness of Treatment Optimisation with Biomarkers for Immunotherapy in Solid Tumours: A Systematic Review 97
Assessment of Healthcare Facilities Associated with JAKi Drugs Used in Rheumatoid Arthritis Patients in Tuscany, Italy: The LEONARDO 87
Oral Presentation: Accesses to Emergency Department and Hospitalizations in New Users of Biologic Therapies for Ulcerative Colitis in Tuscany: The MICHELANGELO Study 83
Circadian typology and cognitive flexibility 73
Correction to: RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks (Orphanet Journal of Rare Diseases, (2020), 15, 1, (347), 10.1186/s13023-020-01631-1) 53
RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks 49
Rehabilitation with and without Robot and Allied Digital Technologies (RADTs) in stroke patients: a study protocol for a multicentre Randomised Controlled Trial on the effectiveness, acceptability, usability, and economic-organizational sustainability of RADTs from subacute to chronic phase (STROKEFIT4) 37
Totale 5.159
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.931
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.931
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022324 0 0 45 44 49 41 12 15 14 10 25 69
2022/2023561 57 92 53 39 56 51 14 21 119 1 55 3
2023/2024357 10 22 31 9 39 59 54 26 4 6 40 57
2024/20251.322 16 38 47 91 81 167 77 54 105 199 154 293
2025/20261.773 147 202 230 156 202 113 284 58 129 154 43 55
2026/2027305 51 236 18 0 0 0 0 0 0 0 0 0
Totale 5.159